- Home
- OLP vs PLRX Comparison
OLP vs PLRX Comparison
Compare OLP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- PLRX
- Stock Information
- Founded
- OLP 1982
- PLRX 2015
- Country
- OLP United States
- PLRX United States
- Employees
- OLP N/A
- PLRX N/A
- Industry
- OLP Real Estate Investment Trusts
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- PLRX Health Care
- Exchange
- OLP Nasdaq
- PLRX Nasdaq
- Market Cap
- OLP N/A
- PLRX 682.2M
- IPO Year
- OLP N/A
- PLRX 2020
- Fundamental
- Price
- OLP $25.76
- PLRX $11.21
- Analyst Decision
- OLP Strong Buy
- PLRX Strong Buy
- Analyst Count
- OLP 1
- PLRX 7
- Target Price
- OLP $28.00
- PLRX $40.50
- AVG Volume (30 Days)
- OLP 67.3K
- PLRX 577.5K
- Earning Date
- OLP 03-04-2025
- PLRX 02-26-2025
- Dividend Yield
- OLP 6.99%
- PLRX N/A
- EPS Growth
- OLP 51.11
- PLRX N/A
- EPS
- OLP 1.63
- PLRX N/A
- Revenue
- OLP $89,142,000.00
- PLRX N/A
- Revenue This Year
- OLP N/A
- PLRX N/A
- Revenue Next Year
- OLP $4.71
- PLRX N/A
- P/E Ratio
- OLP $15.80
- PLRX N/A
- Revenue Growth
- OLP N/A
- PLRX N/A
- 52 Week Low
- OLP $19.25
- PLRX $10.22
- 52 Week High
- OLP $30.45
- PLRX $18.92
- Technical
- Relative Strength Index (RSI)
- OLP 37.32
- PLRX 37.19
- Support Level
- OLP $24.82
- PLRX $11.02
- Resistance Level
- OLP $27.64
- PLRX $12.70
- Average True Range (ATR)
- OLP 0.60
- PLRX 0.80
- MACD
- OLP -0.04
- PLRX -0.18
- Stochastic Oscillator
- OLP 33.33
- PLRX 8.21
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.